DocDollars

Servier Bioinnovation

MA · United States · Reporting entity ID 100001146889

Total reported 2019–2025
$178.3M
#65 of 2,960 reporting companies — 0.2% of all reported industry payments
$1.05M in general payments across 110 records, plus $177.2M in research funding across 10,706 records.

How it breaks down

General payments $1,045,863
Research funding $177,242,293

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Servier Bioinnovation reported $178.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #65 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 110 general payment records and 10,706 research records were filed.

Common questions about Servier Bioinnovation

How much has Servier Bioinnovation paid US doctors?

Servier Bioinnovation reported $178,288,157 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,045,863 in general payments, $177,242,293 in research funding.

How does Servier Bioinnovation rank among drug and device companies?

It ranks #65 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Servier Bioinnovation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.